AFC
BSX icon

Ares Financial Consulting’s Boston Scientific BSX Stock Holding History

Ares Financial Consulting’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.59K Sell
131
-309
-70% -$16.8K ﹤0.01% 688
2026
Q1 		$27.3K Hold
440
– – 0.02% 327
2025
Q4 		$42K Buy
+440
New +$43.1K 0.04% 173

Other funds holding BSX

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Ares Financial Consulting's BSX Position: Q2 2026 in Review

Ares Financial Consulting reduced its Boston Scientific (BSX) stake by 70% in Q2 2026, selling an estimated $16.8K and leaving 131 shares worth $5.59K. The position accounts for ﹤0.01% of the portfolio, ranked #688.

Ares Financial Consulting first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. The position peaked at $42K in Q4 2025. 713 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Ares Financial Consulting held 131 shares of Boston Scientific worth $5.59K as of Q2 2026.
  • Ares Financial Consulting sold 309 Boston Scientific shares in Q2 2026, an estimated $16.8K.
  • Boston Scientific made up ﹤0.01% of Ares Financial Consulting's portfolio in Q2 2026, its #688 holding.
  • Ares Financial Consulting first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
  • Ares Financial Consulting's Boston Scientific position peaked at $42K in Q4 2025.
  • 713 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Ares Financial Consulting's 13F filing for Q2 2026, filed 9 Jul 2026.